Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedMay 24, 2026
DataAggregated Company Financials
Companies20
  • 7D-1.9%
  • 3M10.4%
  • 1Y-29.3%
  • YTD-12.4%

Over the last 7 days, the Healthcare industry has dropped 1.9%, driven by Novo Nordisk declining 3.4%. However, the industry is down 29% over the past year. As for the next few years, earnings are expected to grow by 2.5% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 May 2026DKK 1.7tDKK 468.7bDKK 147.0b20.4x11.6x3.6x
Tue, 21 Apr 2026DKK 1.6tDKK 447.1bDKK 129.9b19.6x12.1x3.5x
Thu, 19 Mar 2026DKK 1.5tDKK 447.9bDKK 130.1b16.4x11.4x3.3x
Sat, 14 Feb 2026DKK 1.8tDKK 448.0bDKK 134.8b15.7x13.5x4.1x
Mon, 12 Jan 2026DKK 2.2tDKK 454.0bDKK 137.0b17.9x16.1x4.9x
Wed, 10 Dec 2025DKK 1.8tDKK 454.0bDKK 137.0b17x13.3x4x
Fri, 07 Nov 2025DKK 1.9tDKK 451.7bDKK 134.4b17.8x13.8x4.1x
Sun, 05 Oct 2025DKK 2.2tDKK 447.3bDKK 141.7b18.3x15.5x4.9x
Tue, 02 Sep 2025DKK 2.1tDKK 447.4bDKK 141.7b24.4x14.9x4.7x
Thu, 31 Jul 2025DKK 1.9tDKK 423.8bDKK 124.7b29.5x15.2x4.5x
Sat, 28 Jun 2025DKK 2.4tDKK 423.1bDKK 124.5b30.5x19.2x5.7x
Mon, 26 May 2025DKK 2.4tDKK 424.3bDKK 125.1b23.4x19.4x5.7x
Wed, 23 Apr 2025DKK 2.2tDKK 409.2bDKK 121.3b20.8x17.9x5.3x
Fri, 21 Mar 2025DKK 2.9tDKK 409.5bDKK 121.3b25.2x24x7.1x
Sun, 16 Feb 2025DKK 3.0tDKK 409.9bDKK 121.5b26.3x24.9x7.4x
Tue, 14 Jan 2025DKK 3.3tDKK 387.5bDKK 111.4b29.4x29.4x8.4x
Thu, 12 Dec 2024DKK 4.1tDKK 387.4bDKK 111.3b31.2x36.5x10.5x
Sat, 09 Nov 2024DKK 3.9tDKK 386.3bDKK 110.7b32.7x35.1x10.1x
Mon, 07 Oct 2024DKK 4.0tDKK 372.0bDKK 107.1b35.8x37.5x10.8x
Wed, 04 Sep 2024DKK 4.7tDKK 372.0bDKK 107.2b35x44.2x12.7x
Fri, 02 Aug 2024DKK 4.7tDKK 355.4bDKK 106.3b36.7x44x13.2x
Sun, 30 Jun 2024DKK 5.0tDKK 355.3bDKK 106.2b35.1x47.4x14.2x
Tue, 28 May 2024DKK 4.7tDKK 355.3bDKK 106.2b37.4x43.8x13.1x
Thu, 25 Apr 2024DKK 4.5tDKK 341.4bDKK 99.6b33.8x45.1x13.2x
Sat, 23 Mar 2024DKK 4.6tDKK 341.2bDKK 99.6b39.7x45.7x13.4x
Mon, 19 Feb 2024DKK 4.4tDKK 340.0bDKK 98.7b34.9x44.3x12.9x
Wed, 17 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b33.4x42.1x11.8x
Fri, 15 Dec 2023DKK 3.5tDKK 320.4bDKK 90.0b33.2x38.7x10.9x
Sun, 12 Nov 2023DKK 3.6tDKK 319.8bDKK 89.9b31.7x39.6x11.1x
Tue, 10 Oct 2023DKK 3.4tDKK 305.5bDKK 82.2b32.5x41x11x
Thu, 07 Sep 2023DKK 3.5tDKK 305.5bDKK 82.2b36.2x42.6x11.5x
Sat, 05 Aug 2023DKK 2.9tDKK 288.2bDKK 74.9b38.5x38.6x10x
Mon, 03 Jul 2023DKK 3.0tDKK 287.1bDKK 75.5b40.3x39.9x10.5x
Wed, 31 May 2023DKK 3.1tDKK 287.1bDKK 75.5b41x40.6x10.7x
Price to Earnings Ratio

40.6x


Total Market Cap: DKK 3.1tTotal Earnings: DKK 75.5bTotal Revenue: DKK 287.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 30.3x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.6x which is lower than its 3-year average PE of 30.3x.
  • The 3-year average PS ratio of 8.7x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.087%
Healthcare-1.90%
Life Sciences5.80%
Medical Equipment3.09%
Healthcare Services2.85%
Biotech2.59%
Healthtech-1.24%
Pharma-2.99%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 33.3x.
    • Analysts are expecting annual earnings growth of 20.3%, which is higher than its past year's earnings growth of 0.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 113% over the next 5 years.
  • In contrast, the Life Sciences industry is expected to see its earnings decline by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.72k2.3%
+DKK 2.4b		26.7%PE20x
DEMANT DemantDKK 247.204.8%
+DKK 2.4b		-4.7%PE22x
ALK B ALK-AbellóDKK 263.004.0%
+DKK 2.3b		51.6%PE45.5x
AMBU B AmbuDKK 68.159.1%
+DKK 1.5b		-32.5%PE37.8x
COLO B ColoplastDKK 403.601.1%
+DKK 968.2m		-35.9%PE43.2x

Latest News

NOVO B
DKK 289.00
Novo Nordisk
7D
-3.4%
1Y
-34.8%
HLUN B
DKK 41.82
H. Lundbeck
7D
1.1%
1Y
12.7%
Analysis Article • 7h

H. Lundbeck's (CPH:HLUN B) Solid Earnings Have Been Accounted For Conservatively

H. Lundbeck A/S' ( CPH:HLUN B ) recent earnings report didn't offer any surprises, with the shares unchanged over the...
BAVA
DKK 197.00
Bavarian Nordic
7D
4.6%
1Y
17.3%
COLO B
DKK 403.60
Coloplast
7D
1.1%
1Y
-35.9%
Analysis Article • May 20

Some May Be Optimistic About Coloplast's (CPH:COLO B) Earnings

Shareholders appeared unconcerned with Coloplast A/S' ( CPH:COLO B ) lackluster earnings report last week. Our analysis...
AMBU B
DKK 68.15
Ambu
7D
9.1%
1Y
-32.5%
Narrative Update • May 19

AMBU B: Lower P/E Expectations Will Support Future Upside Repricing

Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.
NNIT
DKK 40.75
NNIT
7D
-1.6%
1Y
-42.7%
ZEAL
DKK 318.00
Zealand Pharma
7D
2.4%
1Y
-22.2%
GMAB
DKK 1,723.50
Genmab
7D
2.3%
1Y
26.7%
STENO
DKK 1.15
Stenocare
7D
-4.2%
1Y
179.3%
DEMANT
DKK 247.20
Demant
7D
4.8%
1Y
-4.7%
ALK B
DKK 263.00
ALK-Abelló
7D
4.0%
1Y
51.6%
PEG
DKK 0.079
Pharma Equity Group
7D
-1.5%
1Y
-3.7%
STRAP
DKK 590.00
Strategic Partners
7D
-4.8%
1Y
-45.4%